Literature DB >> 19808641

Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice.

Edoardo Zattra1, Christina Coleman, Simin Arad, Elizabeth Helms, Danielle Levine, Evelyn Bord, Alexandra Guillaume, Mohamad El-Hajahmad, Edwin Zwart, Harry van Steeg, Salvador Gonzalez, Raj Kishore, David A Goukassian.   

Abstract

UV-irradiated skin and UV-induced tumors overexpress the inducible isoform of cyclooxygenase-2 (Cox-2), and Cox-2 inhibition reduces photocarcinogenesis. To evaluate photoprotective effects of Polypodium leucotomos extract (PL), hairless Xpc(+/-) mice were fed for 10 days with PL (300 mg/kg) or vehicle then UV-irradiated, once. By 24 hours, UV-induced Cox-2 levels were increased in vehicle-fed and PL-fed mice, whereas by 48 and 72 hours, Cox-2 levels were four- to fivefold lower in PL-fed mice (P < 0.05). p53 expression/activity was increased in PL-fed versus vehicle-fed then UV-irradiated mice. UV-induced inflammation was decreased in PL-fed mice, as shown by approximately 60% decrease (P < 0.001) in neutrophil infiltration at 24 hours, and macrophages by approximately 50% (<0.02) at 24 and 48 hours. By 72 hours, 54 +/- 5% cyclobutane pyrimidine dimers remained in vehicle-fed versus 31 +/- 5% in PL-fed skin (P < 0.003). The number of 8-hydroxy-2'-deoxyguanosine-positive cells were decreased before UV irradiation by approximately 36% (P < 0.01), suggesting that PL reduces constitutive oxidative DNA damage. By 6 and 24 hours, the number of 8-hydroxy-2'-deoxyguanosine-positive cells were approximately 59% (P < 0.01) and approximately 79% (P < 0.03) lower in PL-fed versus vehicle-fed mice. Finally, UV-induced mutations in PL-fed-mice were decreased by approximately 25% when assessed 2 weeks after the single UV exposure. These data demonstrate that PL extract supplementation affords the following photoprotective effects: p53 activation and reduction of acute inflammation via Cox-2 enzyme inhibition, increased cyclobutane pyrimidine dimer removal, and reduction of oxidative DNA damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808641      PMCID: PMC2774059          DOI: 10.2353/ajpath.2009.090351

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

Review 1.  Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.

Authors:  Andrew J Dannenberg; Kotha Subbaramaiah
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

2.  Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice.

Authors:  David A Goukassian; Elizabeth Helms; Harry van Steeg; Conny van Oostrom; Jag Bhawan; Barbara A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

3.  Incidence of nonmelanoma skin cancer in New Hampshire and Vermont.

Authors:  H Serrano; J Scotto; G Shornick; T R Fears; E R Greenberg
Journal:  J Am Acad Dermatol       Date:  1991-04       Impact factor: 11.527

4.  Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study.

Authors:  E L Fosbøl; G H Gislason; S Jacobsen; F Folke; M L Hansen; T K Schramm; R Sørensen; J N Rasmussen; S S Andersen; S Z Abildstrom; J Traerup; H E Poulsen; S Rasmussen; L Køber; C Torp-Pedersen
Journal:  Clin Pharmacol Ther       Date:  2008-11-05       Impact factor: 6.875

5.  Skin photosensitizing agents and the role of reactive oxygen species in photoaging.

Authors:  M Dalle Carbonare; M A Pathak
Journal:  J Photochem Photobiol B       Date:  1992-06-30       Impact factor: 6.252

Review 6.  Role of reactive oxygen species in skin carcinogenesis.

Authors:  Chikako Nishigori; Yukari Hattori; Shinya Toyokuni
Journal:  Antioxid Redox Signal       Date:  2004-06       Impact factor: 8.401

7.  Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents.

Authors:  Geetha Achanta; Peng Huang
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

8.  Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection.

Authors:  Catherine S Tripp; Eric A G Blomme; Kevin S Chinn; Medora M Hardy; Peter LaCelle; Alice P Pentland
Journal:  J Invest Dermatol       Date:  2003-10       Impact factor: 8.551

Review 9.  Cancer and cyclooxygenase-2 (COX-2) inhibition.

Authors:  J F Evans; S L Kargman
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC.

Authors:  A T Sands; A Abuin; A Sanchez; C J Conti; A Bradley
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

View more
  21 in total

1.  The role of the aqueous extract Polypodium leucotomos in photoprotection.

Authors:  Concepción Parrado; Jimena Nicolas; Angeles Juarranz; Salvador Gonzalez
Journal:  Photochem Photobiol Sci       Date:  2020-10-27       Impact factor: 3.982

2.  Protection: the sunscreen pill.

Authors:  Erin Biba
Journal:  Nature       Date:  2014-11-20       Impact factor: 49.962

Review 3.  The globalization of traditional medicine in northern peru: from shamanism to molecules.

Authors:  Rainer W Bussmann
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-28       Impact factor: 2.629

Review 4.  Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.

Authors:  Mark Nestor; Vivian Bucay; Valerie Callender; Joel L Cohen; Neil Sadick; Heidi Waldorf
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

5.  The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study.

Authors:  Indermeet Kohli; Rubina Shafi; Prescilia Isedeh; James L Griffith; Mohammed S Al-Jamal; Narumol Silpa-Archa; Bradford Jackson; Mohammed Athar; Nikiforos Kollias; Craig A Elmets; Henry W Lim; Iltefat H Hamzavi
Journal:  J Am Acad Dermatol       Date:  2017-03-22       Impact factor: 11.527

Review 6.  Use of Polypodium leucotomas Extract in Clinical Practice: A Primer for the Clinician.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01

7.  Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects.

Authors:  Mark S Nestor; Brian Berman; Nicole Swenson
Journal:  J Clin Aesthet Dermatol       Date:  2015-02

8.  Benefits of oral Polypodium Leucotomos extract in MM high-risk patients.

Authors:  P Aguilera; C Carrera; J A Puig-Butille; C Badenas; M Lecha; S González; J Malvehy; S Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-07-31       Impact factor: 6.166

Review 9.  Polypodium Leucotomos--An Overview of Basic Investigative Findings.

Authors:  Brian Berman; Charles Ellis; Craig Elmets
Journal:  J Drugs Dermatol       Date:  2016-02       Impact factor: 2.114

10.  Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of Polypodium Leucotomos Extract in the Treatment of Melasma in Asian Skin: A Pilot Study.

Authors:  Chee-Leok Goh; Sai Yee Chuah; Steven Tien; Guan Thng; María Alejandra Vitale; Arancha Delgado-Rubin
Journal:  J Clin Aesthet Dermatol       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.